• Be Biopharma debuts with $52M to advance engineered B-cell therapies

    1 month ago - By Fierce Biotech

    Be Biopharma debuts with $52M to advance engineered B-cell therapies amysokolow2020
    Wed, 10/21/2020 - 20:39
    Read more ...